Health Management Associates, Inc. Appoints Pascal J. Goldschmidt, M.D. to Board of Directors
NAPLES, Fla.--([ BUSINESS WIRE ])--Health Management Associates, Inc. (NYSE: HMA) today announced the appointment of Pascal J. Goldschmidt, M.D. to its Board of Directors. This appointment increases the number of board members from nine to ten.
"I am very pleased to welcome Pascal to the Board of Directors of Health Management"
Pascal J. Goldschmidt, M.D., an internationally renowned cardiologist and cardiovascular researcher, is senior vice president for medical affairs and dean of the University of Miami Leonard M. Miller School of Medicine. He also serves as chief executive officer of the University of Miami Health System, which includes three hospitals and more than two dozen outpatient facilities in Miami-Dade, Broward, Palm Beach, Monroe and Collier counties, with more than 1,200 physicians and 8,000 staff.
aI am very pleased to welcome Pascal to the Board of Directors of Health Management,a said William J. Schoen, Chairman of the Board of Health Management Associates, Inc. aPascal is an admired leader with diverse experience as a distinguished researcher, notable clinician and proven hospital chief, and his counsel will be invaluable as we navigate the ever-changing health care landscape. We have an outstanding board, and Pascala™s substantial expertise will augment Health Managementa™s focus to enable Americaa™s best local health care.a
Dr. Goldschmidt, whose research applies genomics and cell therapy to the prevention, diagnosis and treatment of coronary artery disease, was previously chairman of the Department of Medicine at Duke University Medical Center. Before taking the chairman's role, he served as chief of Duke's Division of Cardiology.
Before joining the Duke faculty in 2000, he was director of cardiology at The Ohio State University College of Medicine and Public Health, where he built the Heart and Lung Research Institute and launched a heart hospital.
A native of Belgium, Goldschmidt received his medical degree from the Universite Libre de Bruxelles and completed residency and fellowship training in Brussels at Erasme Academic Hospital and in the United States at Union Memorial Hospital and The Johns Hopkins University. Following his training at Hopkins, he served as an assistant, then associate professor, in the university's Division of Cardiology in the Department of Medicine, Department of Cell Biology and Anatomy, and Department of Pathology until 1997.
Dr. Goldschmidt also serves on the boards of Mednax, Inc. (NYSE:MD) and Opko Health, Inc. (AMEX:OPK).
Health Management enables America's best local health care by providing the people, processes, capital and expertise necessary for its hospital and physician partners to fulfill their local missions of delivering superior health care services. Health Management, through its subsidiaries, operates 60 hospitals, with approximately 9,000 licensed beds, in non-urban communities located throughout the United States. All references to aHMAa, aHealth Management,a the aCompanya, awea, ausa or aoura used in this release refer to Health Management Associates, Inc. and its affiliates.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are subject to risks, uncertainties and assumptions and are identified by words such as aexpects,a aestimates,a aprojects,a aanticipates,a abelieves,a aplansa, acoulda and other similar words. All statements addressing operating performance, events or developments that Health Management Associates, Inc. expects or anticipates will occur in the future, including but not limited to projections of revenue, income or loss, capital expenditures, earnings per share, debt structure, bad debt expense, capital structure, repayment of indebtedness, other financial items and operating statistics, statements regarding the plans and objectives of management for future operations, innovations, or market service development, statements regarding acquisitions, joint ventures, divestitures and other proposed or contemplated transactions (including but not limited to statements regarding the potential for future acquisitions and perceived benefits of acquisitions), statements of future economic performance, statements regarding the effects and/or interpretations of recently enacted or future health care laws and regulations, statements of the assumptions underlying or relating to any of the foregoing statements, and other statements which are other than statements of historical fact, are considered to be aforward-looking" statements.
Because they are forward-looking, such statements should be evaluated in light of important risk factors and uncertainties. These risk factors and uncertainties are more fully described in Health Management Associates, Inc.a™s most recent Annual Report on Form 10-K, under the heading entitled aRisk Factors.a Should one or more of these risks or uncertainties materialize, or should any of Health Management Associates, Inc.'s underlying assumptions prove incorrect, actual results could vary materially from those currently anticipated. In addition, undue reliance should not be placed on Health Management Associates, Inc.'s forward-looking statements. Except as required by law, Health Management Associates, Inc. disclaims any obligation to update or publicly announce any revisions to any of the forward-looking statements contained in this press release.